Kathleen Addison is an Executive Director and has been with the Life Sciences banking team for four years. She brings over 25 years of experience in commercial banking to find innovative solutions that assist small- to midcap life sciences companies. Combining her experience with J.P. Morgan’s well-respected healthcare industry expertise and access to key industry leaders, she can provide valued strategic discussion around the impact of R&D, milestones, positive date, the road to commercialization, financing for working capital and preparation for an exit. This enables her to cover each firm’s needs through its life cycle. Kathleen is based in New Jersey.